Fuda Cancer Hospital
Esophageal cancer treatment cost in China runs from $100 to $600 for a diagnostic gastroscopy, while a surgical resection of the esophagus ranges from $26,500 to $49,500. Total expenses depend on cancer staging, the complexity of combined therapies, and whether the facility is public or private. International patients typically save 50-70% compared to US costs. Top treatment hubs include Guangzhou and Xiamen.
Typical Esophageal Cancer Treatment Costs in China
Bookimed Expert Insight: Patients with advanced thoracic malignancies benefit from precision radiotherapy at centers like Xiamen Humanity Hospital. Professor Liu Shixin specializes in IMRT and VMAT protocols for complex esophageal cases. For those seeking non-traditional options, Fuda Cancer Hospital provides over 10 types of minimally invasive therapies. This is ideal for patients who cannot tolerate standard chemotherapy. JCI-accredited facilities in China offer specialized oncology care for late-stage cases reaching over 30,000 international patients.
| China | Turkey | Austria | |
| Radiation therapy for colorectal cancer | from $11,500 | from $7,000 | from $12,000 |
| Radiation therapy for esophageal carcinoma | from $14,500 | from $7,000 | from $20,000 |
| Esophagectomy | from $18,500 | from $23,400 | from $30,000 |
| Chemotherapy for esophageal carcinoma | from $12,500 | from $5,000 | from $12,000 |
| Chemotherapy for breast cancer | from $14,800 | from $1,200 | from $15,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Esophageal cancer treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Esophageal cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Esophageal cancer treatment journey.
Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.
He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.
His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.
The doctor is a renowned expert in minimally invasive cryosurgery for cancer, serving as President and chief surgeon at Fuda Cancer Hospital since 2001. With a focus on oncology and minimally invasive procedures, the doctor has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures, treating patients aged 4 to 94.
Graduating from The Fourth Military Medical University with a specialty in thoracic and cardiac surgery, the doctor has contributed significantly to the field with over 100 published papers. Recognized with awards for outstanding contributions to cryosurgery, the doctor holds vice-presidential roles in both the Asian and International Societies of Cryosurgery.